Apoptotic myocytes generate monocyte chemoattractant protein-1 and mediate macrophage recruitment. 2008

Miyuki Kobara, and Nahoko Sunagawa, and Masaki Abe, and Nana Tanaka, and Hiroe Toba, and Hironori Hayashi, and Natsuya Keira, and Tetsuya Tatsumi, and Hiroaki Matsubara, and Tetsuo Nakata
Dept. of Clinical Pharmacology, Kyoto Pharmaceutical University, 5 Misasagi Nakauchi-cho, Yamashina-ku, Kyoto, Japan. kobara@mb.kyoto-phu.ac.jp

The mechanisms by which apoptotic myocytes are removed by macrophages have not been fully elucidated. This study examined whether apoptotic myocytes actively recruit macrophages by generating monocyte chemoattractant protein-1 (MCP-1) in experiments in vitro and in vivo. Neonatal rat cardiac myocytes were incubated for 4 h in the presence or absence of staurosporine (STS, 0.2-1 mumol/l), an apoptosis inducer. Nuclear staining with DAPI showed that STS induced apoptosis in a dose-dependent fashion. STS (1 mumol/l) caused extensive DNA fragmentation and increased caspase-3 activity compared with a serum-deprived control. MCP-1 mRNA and protein levels in myocytes increased twofold and fourfold, respectively, on STS treatment, and immunochemical staining revealed that apoptotic myocytes expressed MCP-1. To elucidate the role of MCP-1 expressed in apoptotic myocytes to recruit macrophages/monocytes, rat monocytes were incubated in the supernatant of STS-treated myocytes using a trans-well system. The culture medium of STS-treated myocytes recruited monocytes in a MCP-1-dependent fashion. In addition, experiments were performed in vivo using ischemia-reperfused rat hearts. Rats were subjected to 30 min of ligation of the left coronary artery followed by 24 h of reperfusion. After the reperfusion, in the ischemic border myocardium, 17.1 +/- 1.1% of myocytes were terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) positive. Moreover, double staining using the TUNEL technique and immunohistochemistry with MCP-1 antibody showed that 69.8 +/- 3.9% of TUNEL-positive myocytes expressed MCP-1 protein. Concomitantly, activated macrophages infiltrated the areas of apoptosis remarkably. These results suggest that apoptotic myocytes produce MCP-1, which have a critical role in the active recruitment of macrophages.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals

Related Publications

Miyuki Kobara, and Nahoko Sunagawa, and Masaki Abe, and Nana Tanaka, and Hiroe Toba, and Hironori Hayashi, and Natsuya Keira, and Tetsuya Tatsumi, and Hiroaki Matsubara, and Tetsuo Nakata
January 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society,
Miyuki Kobara, and Nahoko Sunagawa, and Masaki Abe, and Nana Tanaka, and Hiroe Toba, and Hironori Hayashi, and Natsuya Keira, and Tetsuya Tatsumi, and Hiroaki Matsubara, and Tetsuo Nakata
February 1999, Kidney international,
Miyuki Kobara, and Nahoko Sunagawa, and Masaki Abe, and Nana Tanaka, and Hiroe Toba, and Hironori Hayashi, and Natsuya Keira, and Tetsuya Tatsumi, and Hiroaki Matsubara, and Tetsuo Nakata
July 1998, Journal of neuroscience research,
Miyuki Kobara, and Nahoko Sunagawa, and Masaki Abe, and Nana Tanaka, and Hiroe Toba, and Hironori Hayashi, and Natsuya Keira, and Tetsuya Tatsumi, and Hiroaki Matsubara, and Tetsuo Nakata
September 2006, The Journal of biological chemistry,
Miyuki Kobara, and Nahoko Sunagawa, and Masaki Abe, and Nana Tanaka, and Hiroe Toba, and Hironori Hayashi, and Natsuya Keira, and Tetsuya Tatsumi, and Hiroaki Matsubara, and Tetsuo Nakata
May 1997, Acta neuropathologica,
Miyuki Kobara, and Nahoko Sunagawa, and Masaki Abe, and Nana Tanaka, and Hiroe Toba, and Hironori Hayashi, and Natsuya Keira, and Tetsuya Tatsumi, and Hiroaki Matsubara, and Tetsuo Nakata
January 2018, International journal of ophthalmology,
Miyuki Kobara, and Nahoko Sunagawa, and Masaki Abe, and Nana Tanaka, and Hiroe Toba, and Hironori Hayashi, and Natsuya Keira, and Tetsuya Tatsumi, and Hiroaki Matsubara, and Tetsuo Nakata
December 2005, Journal of immunology (Baltimore, Md. : 1950),
Miyuki Kobara, and Nahoko Sunagawa, and Masaki Abe, and Nana Tanaka, and Hiroe Toba, and Hironori Hayashi, and Natsuya Keira, and Tetsuya Tatsumi, and Hiroaki Matsubara, and Tetsuo Nakata
May 1996, Molecular medicine today,
Miyuki Kobara, and Nahoko Sunagawa, and Masaki Abe, and Nana Tanaka, and Hiroe Toba, and Hironori Hayashi, and Natsuya Keira, and Tetsuya Tatsumi, and Hiroaki Matsubara, and Tetsuo Nakata
November 2004, Vascular medicine (London, England),
Miyuki Kobara, and Nahoko Sunagawa, and Masaki Abe, and Nana Tanaka, and Hiroe Toba, and Hironori Hayashi, and Natsuya Keira, and Tetsuya Tatsumi, and Hiroaki Matsubara, and Tetsuo Nakata
June 1995, Endocrinology,
Copied contents to your clipboard!